Molecular NeurodegenerationNeurosciencePeer-reviewed journal article
Tau oligomers modulate synapse fate by eliciting progressive bipartite synapse dysregulation and synapse loss
Kristeen A. Pareja-Navarro, Christina D. KingiD, Grant Kauwe, Yani Y. Ngwala, Doyle Lokitiyakul, Ivy WongiD, Aaryan Vira, Yaofu Liu, Jackson H. Chen, Mahima SharmaiD, Gabriel Navarro, Olfat A. MalakiD, Chuankai ZhouiD, Birgit SchillingiD, Tara E. TracyiD
Abstract
BackgroundSynapse function is critical for cognition, and synapse loss is highly correlated with cognitive decline in Alzheimers disease and related dementias. Tau oligomers, which accumulate in the brain in Alzheimers disease, can acutely inhibit synaptic plasticity and cause synapse loss. Coordinated presynaptic and postsynaptic function is essential for effective synaptic transmission, and both compartments can be dysregulated by pathogenic tau. However, the series of pathophysiological events triggered by tau oligomers to cause the dysfunction and deterioration of presynaptic terminals and postsynaptic sites remain unclear. MethodsWe developed a proximity labeling tool to map the postsynaptic proteome by fusing PSD-95 with APEX2 (APEX2-PSD-95) which was expressed in human induced pluripotent stem cell (iPSC)-derived neurons. We used APEX2-PSD-95 to map the dynamic changes in the postsynaptic proteome with precise temporal resolution after an acute exposure of human iPSC-derived neurons to recombinant tau oligomers for 30 min. Leveraging immunocytochemistry, electrophysiology and electron microscopy, we further delineated the impact of the acute tau oligomer exposure on presynaptic and postsynaptic compartments over time for up to 14 days. ResultsThe brief exposure of human iPSC-derived neurons to tau oligomers caused a progressive deterioration of synapses, marked by both presynaptic and postsynaptic dysregulation. Postsynaptic proteome mapping revealed an immediate tau oligomer-triggered downregulation of the postsynaptic actin motor proteins Myosin-Va and Myosin-10, which coincided with impaired AMPA receptor (AMPAR) trafficking during synaptic plasticity. This was followed 24 hours later by the upregulation of disease-related proteins, including GSK3{beta}, at postsynaptic sites. The loss of PSD-95-labeled postsynaptic sites at 7 days after tau oligomer exposure preceded the loss of Synapsin-labeled presynaptic terminals at 14 days. The postsynaptic sites that remained exhibited a long-term downregulation of postsynaptic AMPAR levels and sustained synaptic plasticity impairment. Moreover, the remaining presynaptic terminals contained less clusters of vesicles at the presynaptic active zone which was associated with reduced vesicle release probability at synapses. ConclusionOur findings reveal the series of events underlying tau oligomer-induced bipartite synapse deterioration. The progressive decline of synapses involves the emergence of two synapse fates. One synapse fate involves the persistent weakening of both presynaptic and postsynaptic function, and the other results in synaptic loss.
- Citations
- 4
- FWCI
- 18.49
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synaptic alterations associated with disrupted sensory encoding in a mouse model of tauopathy
Soraya Meftah, Annalisa Cavallini, … Jonathan Witton·Brain CommunicationsPeer-reviewed·Jan 1, 2024
- Differential aberrant structural synaptic plasticity in axons and dendrites ahead of their degeneration in tauopathy
Johanna Jackson, James D. Johnson, … Michael C. Ashby·bioRxiv·Apr 29, 2020
- Distinctive alteration of presynaptic proteins in the outer molecular layer of the dentate gyrus in Alzheimer's disease
Hazal Haytural, Tomás Jordá-Siquier, … Gaël Barthet·Brain CommunicationsPeer-reviewed·Apr 1, 2021
- GPCR-mediated clearance of tau in post-synaptic compartments attenuates tau pathology in vivo
Ari W. Schaler, Avery M. Runyan, … Natura Myeku·bioRxiv·Jan 21, 2020
- Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease
Emre Fertan, Shekhar Kedia, … David Klenerman·Acta NeuropathologicaPeer-reviewed·Jan 23, 2026
- The tau oligomer antibody APNmAb005 detects early-stage pathological tau enriched at synapses and rescues neuronal loss in long-term treatments
Hwan‐Ching Tai, Haou-Tzong Ma, … Chin‐Yin Tai·bioRxiv·Jun 24, 2022